Skip to main content
. 2020 Apr 3;10:387. doi: 10.3389/fonc.2020.00387

Figure 1.

Figure 1

Differential expression of miRNAs in CSF from discover cohort. (A) The overlapping miRNAs differentially expressed between two comparison models (LMs, n = 10; BMs, n = 5; NCs, n = 5); (B) Heatmap of differentially expressed CSF miRNAs analyzed by microarray between LMs (n = 10) and non-LMs controls (BMs, n = 5; NCs, n = 5); (C) Heatmap of differentially expressed miRNAs analyzed by microarray in paired CSF samples from 6 LM patients at diagnosis and after initial LM-directed therapy. Fold change ≥2 or ≤0.5 was regarded as statistically significant. CSF, cerebrospinal fluid; LMs, leptomeningeal metastases; BMs, brain metastases; NCs, non-cancers.